Parkinson Disease: A Model of National Digital Interventions to Prevent or Slow a Rise of Non-Communicable
NCT ID: NCT06609681
Last Updated: 2024-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
10000 participants
OBSERVATIONAL
2024-01-01
2033-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is estimated that the prevalence of Parkinson's disease is approximately 242.57 per 100,000 people of all elderly people, and it is likely to increase due to the current situation of Thailand which is entering aging society. The current diagnosis of Parkinson's disease still relies heavily on medical history and physical examination. The accuracy of diagnosing Parkinson's disease by neurologists is approximately 80 percent, especially when they have been following up consistently. Nonetheless, if they have Parkinson's disease in the early stages, the signs and symptoms will not be severe. Therefore, diagnostic accuracy will decrease around 40-50 percent, making it difficult to diagnose Parkinson's disease patients at an early stage and as a consequence, there still are many undiagnosed patients in 2022. Consequently, Parkinson's Disease Medical Center of Excellence is planning to establish this pilot research project to develop and analyze advanced data of the screening system for people at risk and precursor symptoms to Parkinson's disease, Chulalongkorn Hospital, Thai Red Cross Society. Dividing patients into 3 groups, those who have precursor symptoms, who are at risk of developing disease and Parkinson's disease patients, using the digital platform on mobile application that includes general information, health information, congenital diseases, regularly used medications, initial abnormal symptoms, various risk factors, writing and handwriting, pronunciation assessments, and get diagnosis from experts for referral in the public health system.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence and Characteristics of Restless Leg Syndrome in Thai Patients With Parkinson's Disease
NCT06684782
Hereditary Parkinson s Disease Natural History Protocol
NCT02511015
Digitised Home Based Care for Parkinson's Disease
NCT05544305
Nocturnal Parkinson's Disease Symptoms Study Group
NCT01662427
Web-based Genetic Research on Parkinson's Disease
NCT01351467
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Principal Investigator: Roongroj Bhidayasiri
3. Study centers and Address: Chulalongkorn Center of Excellence for Parkinson's disease and related to movement disorder 1183 RAMA 4 Rd. Pathum wan, Bangkok 10330 and 76 provinces of Thailand.
The Screening of Parkinson's patients with digital technology and sensors and analyze with artificial intelligence the following information
1. Innovative prototype questionnaire. Screening of Parkinson's patients with digital technology.
2. Sound screening that can detect speech
3. Handwriting test by writing sentences and spiral circles.
4. Testing finger dexterity and alternating tap test
5. Tremor analysis
6. Gait analysis
7. Assessing your ability to get out of bed
8. Sleep quality
9. Sleep assessment by polysomnography test
10. Ability to smell
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Family history with Parkinson's disease.
Exclusion Criteria
40 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Roongrooj Bhidayasiri
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Roongrooj Bhidayasiri
Chulalongkorn Center of Excellence for Parkinson is disease and related to movement disorder
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Professor Roongroj Bhidayasiri, M.D.
Role: PRINCIPAL_INVESTIGATOR
Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chulalongkorn Center of Excellence for Parkinson's disease and related to movement disorder
Pathum Wan, Bangkok, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GCE 3300160003
Identifier Type: OTHER
Identifier Source: secondary_id
Med Chula IRB No.0804/65
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.